Connect with us

Politics

U.S. Won’t Join WHO-led Effort to Find and Distribute Coronavirus Vaccine

Published

on

  • On Tuesday, the Trump administration announced that the United States will not join an effort led by the World Health Organization that aims to find and distribute a coronavirus vaccine.
  • So far, 172 countries have expressed interest in the initiative, but the U.S. response has been criticized as “vaccine nationalism.”
  • In part, the W.H.O.-led effort seeks to ensure that poorer countries will also have access to vaccines based on their case-load.
  • One major problem that could arise is a U.S. hoarding of vaccines. If that were to be the case, many Americans would likely still be vulnerable to international cases, as the first approved vaccine will likely not offer full protection.

U.S. Won’t Join W.H.O. Vaccine Efforts 

The Trump administration announced Tuesday that it would not be joining a World Health Organization-led effort that seeks to find and distribute a coronavirus vaccine around the world.

“The United States will continue to engage our international partners to ensure we defeat this virus,” White House spokesperson Judd Deere explained, “but we will not be constrained by multilateral organizations influenced by the corrupt World Health Organization and China.”

Deere’s comment fall back on an argument that the Trump administration has made for months: the W.H.O. is too “China-centric.” In July, the Trump administration formally began the process to withdraw from the W.H.O. because of such criticism.

So far, 172 countries have engaged in discussions to participate in the W.H.O.-led vaccine effort, known as the COVAX initiative. 

That program aims for several outcomes, with the ultimate goal of distributing 2 billion doses of safe and effective vaccines by the end of next year. 

One of the main objectives of the Covax effort is to avoid a situation where vaccine access is limited to countries that have either produced the vaccine or can afford to buy large quantities. 

For example, Covax aims to distribute vaccines based on population size, prioritizing health care workers and vulnerable people. It also plans to set aside a portion that can be sent to hot spots if they should arise. 

The idea of the initiative is that such a method will allow wealthy and middle-income countries to help fund the development of at least nine current vaccine candidates, while also allowing poorer countries to receive vaccines based upon need. By doing this, the Covax effort hopes to avoid repeating what could essentially be a much more deadly repeat of the 2009 H1N1 vaccine, which was hoarded by rich countries.

“Vaccine Nationalism” Criticism

While rich countries such as the United Kingdom and Japan have expressed interest in the initiative, the U.S. now faces criticism and concern over its decision to opt out the effort. 

Experts have chiefly pointed to one of two scenarios. 

The first, which is unlikely but still possible, would be that none of the U.S. candidates are viable, leaving the United States with no option because it shunned the Covax effort. 

As The Washington Post describes it, this could prove to be a potentially risky move because “it eliminates the chance to secure doses from a pool of promising vaccine candidates.”

Kendall Hoyt, an assistant professor from Dartmouth’s School of Medicine, told The Post that such a move is like deciding to opt out of an insurance policy. Hoyt argued the U.S. could be pursuing bilateral deals with drug companies while participating in Covax at the same time.

According to reports, Health and Human Services Secretary Alex Azar had expressed interest in bringing the U.S. into the Covax effort, but that failed after he was met with resistance from government officials who argued that the U.S. already had enough coronavirus vaccine candidates. 

The second outcome is that the U.S. does develop an effective vaccine but hoards it, vaccinating a large number of Americans — including those at lower risk of catching or contracting a particularly bad case of COVID-19 — while leaving other countries without.

Of course, many would ask: shouldn’t the U.S. take care of its own citizens first? The problem, according to experts, is that the first vaccine approved in the U.S. likely won’t offer full protection. That means some Americans might still be vulnerable to imported cases. 

In other words, experts say that the less people who receive the vaccine internationally, the greater the risk of the coronavirus spreading even more in the U.S.

On top of that, U.S. economic recovery is also going to depend on economic recovery in other parts of the world. There, many have pointed back to a statement last month from the W.H.O. Director General Tedros Adhanom Ghebreyesus, who warned against “vaccine nationalism.”

“For the world to recover faster, it has to recover together, because it’s a globalised world: the economies are intertwined,” he said. “Part of the world or a few countries cannot be a safe haven and recover.”

Still, the  Trump administration has defended its efforts to continually distance itself from the W.H.O. For example, it has argued that the U.S. is akin to an airplane passenger securing its own oxygen mask before helping others,

“You put on your own first, and then we want to help others as quickly as possible,” Food and Drug Administration senior official Peter Marks said in June. 

However, as columnists for Foreign Affairs argued, “The major difference, of course, is that airplane oxygen masks do not drop only in first class — which is the equivalent of what will happen when vaccines eventually become available if governments delay providing access to them to people in other countries.”

When Could A COVID Vaccine Come?

One of the lasting questions of the pandemic is: When will the public start seeing vaccines being made readily available?

Unfortunately, that answer is still unknown, but two major health officials have recently suggested that a vaccine could come early. 

On Sunday, FDA Commissioner Stephen Hahn told the Financial Times that the FDA might authorize a vaccine before Phase 3 trials are completed.

“It is up to the sponsor to apply for authorization or approval, and we make an adjudication of their application,” Hahn said. “If they do that before the end of Phase 3, we may find that appropriate. We may find that inappropriate. We will make the decision.”

To be clear, Hahn’s language here is fairly specific. It will almost certainly fall under the umbrella of “if the benefits outweigh the risks.” Nonetheless, the news was significant if for no other reason than Hahn indicated that the agency was willing to potentially make such a move. 

Then, on Tuesday, Dr. Anthony Fauci, the nation’s leading infectious disease expert, told Kaiser Health News that clinical trials could be stopped early if they provide overwhelmingly positive results that show a vaccine is safe and effective.

Fauci said scientists would have a “moral obligation” to make the vaccine available to all participants in the study if that were the case, thus speeding up that vaccine’s ability to hit the public.

Neither Fauci or Hahn’s comments have come without some level of concern. Many worry that both could be influenced by President Donald Trump’s rush to make a vaccine available. Last month, Trump even suggested that a vaccine could be ready as early as Election Day in November. 

As far as Fauci’s comments go, the body that has the power to end trials early is the Data and Safety Monitoring Board. Notably, it is independent and not controlled by the executive branch. In fact, its members are not even government workers. Because of that, Fauci said any decision the board makes isn’t going to be influenced by the president.

Hahn has also denied that the FDA will submit to pressure from the Trump administration, but concern that Trump is pressuring the FDA to give the green light on unproven coronavirus treatments is nothing new.

Last week, the FDA issued an emergency use authorization for plasma recovered from COVID patients despite concerns that plasma might not be as effective as Trump had indicated. In fact, on Tuesday, the National Institutes of Health stressed that there is “insufficient data” to show whether plasma is or isn’t a safe, effective treatment.

See what others are saying: (Axios) (CBS News) (NBC News)

Politics

Campaign Season Gets Rolling This Month With Primaries in 13 States

Published

on

Several of the contests taking place this month will serve as important tests for Trump-backed candidates and how much power the former president still has over the GOP.


May Primaries Start With Key Race in Ohio

The 2022 midterm season is officially heating up this month with 13 states heading to the polls.

Voters in Indiana and Ohio will kick off the busy month on Tuesday with several highly anticipated races, including one closely watched contest for the seat being vacated by long-time Senator Rob Portman (R-Oh.)

The fight for Portman’s seat has been a heated one: candidates have spent tens of millions of dollars, held numerous debates and forums, and at one point, two of them even got into a physical confrontation. 

The main reason there are so many eyes on this race is because it will prove to be a key test for former President Donald Trump and the influence he has over the party. While Portman has generally been moderate and, at times, more readily critical of Trump than many others in his party, the Republican primary campaign has basically been a fight to see who is the most in line with Trump.

According to FiveThirtyEight, all but one of the seven Republican senate candidates embraced the former president’s election fraud lies as they fought for his coveted endorsement in a state he won by eight points in both 2016 and 2020.

Trump, for his part, ultimately ended up endorsing Hillbilly Elegy author J.D. Vance in a move that surprised many, because Vance had previously been vocally opposed to the former leader and his competitors had spent months running ads noting that fact.

However, the fight for Trump’s backing appears to have been worth it. Last week, a Fox News poll found that support for Vance has surged by double-digits since Trump’s endorsement, making him the front-runner.

Still, as FiveThirtyEight reports, “other factions of the party haven’t given up the fight either — which means the primary will be a direct test of how much clout Trump has when other Republican elites dare to defy him.” 

Meanwhile, there are also concerns regarding the ongoing legal battle over Ohio’s congressional map and the confusion that has caused for the state’s election calendar. For weeks, it was widely believed the state’s primaries would be pushed back after the Ohio Supreme Court ordered GOP lawmakers to redraw their map.

The map had been gerrymandered to give Republicans 12 out of the 15 congressional seats in the state even though they had only won around 55% of the popular vote. Ohio voters also previously passed a constitutional amendment in 2018 that effectively banned partisan gerrymandering.

The election, however, is still going forward anyway, even as early voting was down a whopping 40% from the last election, and the legislative races will not be on the ballot Tuesday, meaning there will have to be a second primary, which will likely drive down turnout even more.

Other Major Races This Month

There are also other notable contests scheduled for later this month. On May 17, there will be two additional races for seats vacated by Republican senators in North Carolina and Pennsylvania that will serve as important indicators of the former president’s sway over the party.

Meanwhile, in Georgia, the main Trump test focuses on two statewide races for the positions currently held by Gov. Brian Kemp (R) and Secretary of State Brad Raffensperger (R). The two infamously angered Trump after they refused to help him overturn the election, and as a result, many are watching to see if the former president’s full-fledged pressure campaign against them will work.

In Georgia and other battlegrounds voting this month, Democrats are also hoping they can make inroads — particularly in Pennsylvania. But recent polls have not painted a good picture for the party. Last week, an NPR/PBS NewsHour/Marist poll found that 47% of voters said they were more likely to vote for the Republican in their district, while just 44% said they would back Democrats. 

The poll marked the first time in eight years that a Marist survey found the GOP with an advantage for congressional ballot tests. 

See what others are saying: (NPR) (FiveThirtyEight) (PennLive)

Continue Reading

Politics

New York’s Highest Court Strikes Down Democrat-Gerrymandered Map

Published

on

The move represents a major blow to Democrats, who stood to gain as many as three seats in Congress if their map had been accepted.


Appeals Court Ruling

The New York State Court of Appeals struck down a congressional map drawn by the state’s Democrats Wednesday, dealing the party a major blow.

In the decision, the state’s highest court agreed with Republicans who had argued that the map was unconstitutionally gerrymandered to benefit Democrats. The justices called the map “substantively unconstitutional as drawn with impermissible partisan purpose.”

The court also condemned the Democrats for ignoring a constitutional amendment approved by voters in 2014 that aimed to limit political influence in redistricting, which included the creation of an independent entity to draw maps that the legislature would then vote on. However, the commission created to prevent partisan gerrymandering was unable to decide on a map because of its own partisan stalemate. As a result, Democrats in the legislature took it upon themselves to draw a final map.

But the version that the legislature passed and New York Gov. Kathy Hochul (D) signed into law re-drew lines so that Democrats could have gained as many as three new seats in the U.S. House of Representatives. 

Such gains would be highly significant in the upcoming 2022 midterm elections, where Republicans are expected to make substantial gains and may very well take back the House. Unsurprisingly, Republicans sued, and a lower court struck down the map.

In their order, the Appeals Court justices took away the legislature’s ability to make the map and instead delegated that power to a court-appointed “neutral expert.” 

While the judges did say there was enough time to finish the map before the primary elections in June, they also added that the Congressional contests would likely need to be moved to August. Races for governor and other statewide officials, however, would stay the same.

Broader Trends

The Appeals Court ruling is unique in that it targets Democrats, but it also comes as part of the broader trend of state courts cracking down on gerrymandering — though most other instances have stemmed from GOP-drawn maps.

In just the first four months of 2022, state courts in Ohio, North Carolina, Kansas, and Maryland have all struck down redistricting plans crafted by lawmakers.

Unlike the New York ruling, some of those other courts have implied that they will still allow those maps to be used in the 2022 elections. Such a decision would very likely disadvantage Democrats even more.

See what others are saying: (The New York Times) (NPR) (The Washington Post)

Continue Reading

Politics

McCarthy Warned Far-Right Lawmakers Could Incite Violence After Jan. 6 in New Audio of Leaked Call

Published

on

The conversations represent a marked difference from the public efforts of McCarthy and other Republican leaders to downplay their members actions.


Leaked Audio

Four days after the Jan. 6 insurrection, House Minority Leader Kevin McCarthy (R-Ca.) expressed concern about far-right Republicans inciting violence and openly voiced support for censoring them on Twitter, according to audio published by The New York Times on Tuesday.

The recordings, which come from a call among party leaders and aides on Jan. 10, are by far the clearest evidence top Republicans acknowledged that their members played a role in stoking violence before the insurrection and threatened to do so after.

They also emphasize the vast difference between what top Republicans, especially McCarthy, said behind closed doors, and how they downplayed and ignored the actions of their members in public. 

One of the most notable elements of these recordings is that McCarthy and the others explicitly identified several individuals by name. They focused mainly on Reps. Matt Gaetz (R-Fl.) and Mo Brooks (R-Al.) as the primary offenders.

In the audio, McCarthy can be heard flagging Gaetz right off the bat.

“Tension is too high. The country is too crazy,” he added. “I do not want to look back and think we caused something or we missed something and someone got hurt. I don’t want to play politics with any of that.” 

Specifically, McCarthy and the others talked about how Gaetz had gone on TV to attack multiple Republicans for being unsupportive of former President Donald Trump after Jan. 6. They particularly expressed concern over his targeting of Rep. Liz Cheney (R-Wy.), who was a member of the leadership team and had already been facing threats.

Others on the call also noted that Brooks had spoken at the rally before the insurrection, where he made incendiary remarks that many have viewed as direct calls to violence. McCarthy said the public comments from his members “have to stop,” adding he would call Gaetz and have others do the same to tell him that this “is serious shit” and “to cut this out.”

Rep. Steve Scalise (R-La.), the second-ranking House Republican, asserted at one point that Gaetz’s actions were “potentially illegal.” 

“Well, he’s putting people in jeopardy, and he doesn’t need to be doing this,” McCarthy responded. “We saw what people would do in the Capitol, you know, and these people came prepared with rope, with everything else.”

Republicans on the call also mentioned incendiary remarks from other members, including Reps. Louie Gohmert (R-Tx.), Barry Moore (R-Al.), and Lauren Boebert (R-Co.). Cheney pointed to Boebert as a security risk, noting she had tweeted out incredibly sensitive information about the movements of top leaders like House Speaker Nancy Pelosi (D-Ca.) during the attack on the Capitol.

“Our members have got to start paying attention to what they say, too, and you can’t put up with that shit,” McCarthy added later. “Can’t they take their Twitter accounts away, too?”

McCarthy in Hot Water

The newly published recordings also come just days after The Times reported that McCarthy had told members on a call after the insurrection that he would urge Trump to resign.

McCarthy initially called the reporting “totally false and wrong,” but shortly after his denial, The Times received permission from their source to publish audio where he can be heard saying precisely that.

McCarthy, for his part, has tried to spin the situation, claiming that his remarks were still true because he never actually followed through on the plan to call Trump. 

Still, the situation prompted widespread backlash from the far-right faction of the Republican party. 

Multiple people expressed hesitancy about their support for McCarthy as Speaker of the House if Republicans take control of the chamber in the midterm elections. Some said they could not trust him.

Speaking on his show Tuesday, Foxs News host Tucker Carlson called McCarthy “a puppet of the Democratic Party.”

Gaetz also responded with ire, tweeting out a statement in which he referred to the call as “sniveling” and said of McCarthy and Scalise: “This is the behavior of weak men, not leaders.”

Other members mentioned in the call, however, appeared to brush it off. In a statement to Axios, Moore claimed that the story was engineered by “RINOS” (Republicans in Name Only), and that “Republicans will be more united than ever after taking back the House this November.”

It currently remains unclear whether these revelations with pose any long-term threat to McCarthy, but if Trump is any indication of the far-right party line, the House leader may be in the clear.

After The Times published the audio of McCarthy saying Trump should resign, the former president told The Wall Street Journal that the relationship between the two men was untroubled.

“I think it’s all a big compliment, frankly,” he added. “They realized they were wrong and supported me.”

See what others are saying: (The New York Times) (Axios) (The Washington Post)

Continue Reading